ОбзорГрафикНовостиTraderScreen

Morgan Stanley Knock-Out PRY/  DE000ME4KNF2  /

Stuttgart
30.05.2024  21:28:04 Изменение- Бид9:18:48 Предложение9:18:48 Базовый актив Цена исполнения Дата истечения Тип опциона
2.66EUR - 2.62
Величина цены спроса: 40,000		 2.63
Величина цены предложения: 40,000		 PRYSMIAN 32.8589 EUR 31.12.2078 Call
GlobeNewswire 9:30 XTCC partners with Circulariti to support sustainability and carbon neutrality in the end to end fa...
GlobeNewswire 9:15 HSBC Continental Europe: Post Stabilisation Notice
Newsfile Corp 9:06 me88 Launches me scoreAI: Revolutionizing Football Predictions for UEFA Euro Cup 2024
Newsfile Corp 9:01 ReGen III Announces Closing of Initial Tranche of Convertible Debenture Offering
TeleTrader 9:00 Europe opens mixed ahead of CPI data
GlobeNewswire 9:00 insightsoftware to Strengthen xP&A and Write-Back Capabilities in Qlik With Fiplana Acquisition
TeleTrader 8:57 China says not providing arms to any side in Ukraine conflict
TeleTrader 8:48 French inflation unchanged at 2.2% in May
TeleTrader 8:44 NATO chief: Kremlin escalation threat not new
TeleTrader 8:30 Swiss retail sales up 2.7% in April
GlobeNewswire 8:14 STMicroelectronics to build the world’s first fully integrated silicon carbide facility in Italy
GlobeNewswire 8:09 DePIN Mining Aggregator ‘Hivello’ Launches Private Beta Application
TeleTrader 8:00 Annual UK house prices up 1.3% in May
TeleTrader 8:00 German retail sales down 0.6% in April
GlobeNewswire 8:00 Nyxoah Announces Closing of Offering and Partial Exercise of Option to Purchase Additional Shares
TeleTrader 7:55 Europe higher premarket ahead of economic data
GlobeNewswire 7:54 Flash News: OKX Wallet Now Integrated with DIN
TeleTrader 7:50 OPEC+ reportedly seen extending cuts further
TeleTrader 7:41 Russian forces strengthen position in Donesk
GlobeNewswire 7:30 Baosheng Media Group Holdings Limited Announces Filing of Current Report on Form 6-K with the SEC re...
TeleTrader 7:19 Asia-Pacific mostly higher after China, Japan data
GlobeNewswire 7:05 Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD
GlobeNewswire 7:05 Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD
GlobeNewswire 7:00 Update on FDA Priority Review of Dupixent® (dupilumab) for the Treatment of COPD Patients with Type ...
GlobeNewswire 7:00 Press Release: Update on FDA priority review of Dupixent for the treatment of COPD patients with typ...